XTalks

DECEMBER 17, 2021

Xtalks is taking a look at some of the major stories and innovations of the year in the life sciences, many of which were driven by new, emerging and improved technologies. The year 2021 was all about continuing innovations in the life sciences. Life Science Innovations: Malaria and Influenza Vaccines.

Life Science 98

Life Science Vaccination Vaccine Trials 98

Roots Analysis

AUGUST 28, 2022

The up-and-coming field of spatial genomics in biology promises to bridge the gap between high plex, high throughput, and high resolution. 70+ spatial Genomics solutions are developed by industry and non-industry players. 70+ spatial Genomics solutions are developed by industry and non-industry players. Concluding Remarks.

Genome 52

Genome Genomics RNA Genome Project 52

Drug Discovery World

MAY 10, 2023

The winners of the award will receive proteomic data from SomaLogic’s 7,000-plex assay, which will be run at Singapore-based Molecular Genomics. Researchers can apply on SomaLogic’s website: [link] Life science researchers in Asia are now increasingly appreciating the power and the promise of proteomics in their discovery efforts.

Research 52

Research Life Science Genome Genomics 52

Drug Discovery World

FEBRUARY 12, 2024

Leslie Orne, President and CEO, Trinity Life Sciences “AI and ML will play an increasingly important role in the clinical development and commercialisation of cell and gene therapies, which are typically targeted to small patient populations.

Genome 139

Genome Genomics Life Science Gene Therapy 139

XTalks

MAY 23, 2024

Eterovic brings much knowledge and experience to the table, having led the development of a new Oncology Diagnostic program at Eurofins Viracor that integrates the latest genomic profiling techniques. Eterovic highlights that the financial and logistical barriers to comprehensive genomic profiling are high but not impossible to overcome.

Genetics 109

Genetics Research Genome Genomics 109

pharmaphorum

OCTOBER 7, 2021

However, developments in genomic medicine are making huge strides to improve this situation, and these will also be discussed during the webinar. His academic and clinical focus is on benign haematology, where he has a particular interest in sickle cell disease, haemophilia and other rare blood disorders. About IQVIA.

Genome 98

Genome Genomics Medicine Life Science 98

XTalks

MAY 20, 2022

Doctors and physicians rely on the results provided by a clinical scientist to make an accurate prognosis, diagnosis and assessment for a patient’s treatment plan. What is it Like to Work as a Clinical Scientist? A clinical scientist is often synonymous with: Clinical Research / Clinical Laboratory Scientist.

Scientist 105

Scientist Life Science Clinical Research Doctors 105

XTalks

FEBRUARY 1, 2021

Montreal, Canada-based Caprion Biosciences announced last week that the clinical research organization (CRO) will rebrand as CellCarta. The move follows the 2019 merger between Caprion and HistoGeneX , a Belgian histopathology and genomics lab.

Life Science 98

Life Science Branding Genome Genomics 98

XTalks

MAY 22, 2024

Exact Sciences (Overall Rank 281) Exact Sciences , founded in 1995, is a molecular diagnostics company specializing in early cancer screening and diagnostic tests. Exact Sciences is also investing in its pipeline to develop innovative solutions before, during and after a cancer diagnosis. Thermo Fisher Scientific boasts a $42.86

Life Science 66

Life Science Production FDA Approval Development 66

Drug Discovery World

OCTOBER 16, 2023

Maina Bhaman, Partner at Sofinnova Partners, says: “The UK is an attractive space for drug discovery companies and a prime environment for investment due to its talent, infrastructure, and genomics research. CellProthera also appointed the Newcastle Centre for Life’s GMP cell therapy centre to produce the ATMP.”

Drugs 75

Drugs Life Science Gene Therapy Genome 75

pharmaphorum

MARCH 16, 2021

International deep real-world evidence company Savana is on a mission to give health researchers the power to unlock the clinical value embedded within electronic health records (EHRs) using artificial intelligence (AI) and clinical Natural Language Processing (NLP) techniques. AI use in the pandemic.

Doctors 113

Doctors Doctor Life Science Clinical Research 113

Drug Discovery World

APRIL 29, 2024

Bill Dawson, Chair, Medicines Manufacturing Industry Partnership (MMIP): Dawson is Head of Biologics and Devices Manufacturing at GSK and has over 25 years’ experience in the vaccines, biopharma, pharmaceutical and clinical research (CRO) industries. He is lead inventor on 28 US patents linked to genome sequencing.

Drugs 52

Drugs Sales Gene Therapy Life Science 52

XTalks

JANUARY 17, 2024

Lupus, a complex autoimmune disease, has brought a substantial challenge to researchers and healthcare professionals. Understanding this condition and its various manifestations, as well as developing effective treatments, has been the focus of ongoing investigation in lupus clinical research for many years.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Life Science 52

pharmaphorum

APRIL 23, 2020

to 13.30 (BST) / 07:30 to 08:30 (EST).

Genome 40

Genome Genomics Life Science Clinical Trials 40

XTalks

MAY 23, 2024

With over 25 years of experience, Dr. Duke’s expertise in growth and bone disorders has been instrumental in advancing clinical research and improving patient outcomes. Advancements in genomic technology, precision medicine and gene therapy offer hope for personalized treatments and improved outcomes.

Clinical Trials 52

Clinical Trials Clinical Trials Hormones Trials 52

The Pharma Data

JANUARY 17, 2021

Unburdened access to high quality data, including physician notes and genomics will offer benefits across the spectrum of healthcare from clinical decision support in the hospital to the full lifecycle of drug development but for health conditions beyond COVID-19. rows of data. About Syntegra. .

Life Science 52

Life Science Engineer Big Data Scientist 52

The Pharma Data

NOVEMBER 20, 2020

–( BUSINESS WIRE )– Biocom California , the association representing the California life science industry, issued the following statement in response to the release of the Most Favored Nation (MFN) Model by the Centers for Medicare and Medicaid Services (CMS) today. 21, 2020 03:50 UTC. About Biocom California.

Life Science 40

Life Science Genome Genomics Research 40

pharmaphorum

NOVEMBER 9, 2020

COVID-19 has sparked a flurry of research and discoveries are being made at an unprecedented rate – but patient participation cannot and should not be left behind in the rush, say leading voices. It means that without a cross-sector plan to get trials back up a running, a decade of research could be lost to the COVID-19 crisis.

Clinical Trials 73

Clinical Trials Clinical Trials Clinical Research Research 73

XTalks

FEBRUARY 4, 2021

The power of leveraging clinical data to decipher disease mechanisms and fuel drug discovery has rapidly grown in the era of genomics and personalized medicine. Partnerships and Establishing Research Cohorts. Genomic biomarker discovery helps drive the development of innovative new personalized therapies.

Research 98

Research Biobanking Drugs Genome 98

pharmaphorum

JULY 4, 2022

And this is where modern technologies and data-driven medical informatics can really bridge the gaps in rare disease research,” said Dr Joanne Hackett, head of Genomic and Precision Medicine at IQVIA, during a recent pharmaphorum webinar.

Genome 104

Genome Genomics Research Medicine 104

Crucial Data Soutions

AUGUST 6, 2020

Today, clinical data comes in different forms from a plethora of sources: electronic patient-reported outcomes (ePRO), wearables/internet of medical things (IoMT), imaging, biologics, genomics, and more. While these data sources are not necessarily new, the COVID-19 pandemic has created a shift in how they’re perceived and adopted.

Clinical Trials 72

Clinical Trials Clinical Trials Trials Genome 72

pharmaphorum

FEBRUARY 10, 2022

These included computational and digital skills, the integration of clinical, industrial, and economic research, and genomic and phenotypic insights. People with the ability to integrate data across the patient pathway, in order to aid both research and treatment development, are, the report says, in particularly high demand.

Life Science 103

Life Science Genome Genomics Research 103

XTalks

DECEMBER 1, 2020

Fortunately, technological advances — such as those pioneered by Menarini Silicon Biosystems — have allowed researchers and healthcare practitioners to decipher these issues, drilling down to single-cell genomic levels to uncover variations that may account for reduced drug efficacy or biochemical resistance.

Clinical Trials 96

Clinical Trials Clinical Trials Trials Clinical Research 96

The Pharma Data

NOVEMBER 5, 2020

Prior to Lonza, she led External Science and Partnering across the globe for Sanofi R&D. Previously, he was an associate director at Navigant Life Science Consulting. Deep Genomics – Toronto-based Deep Genomics appointed Amanda Kay to the newly-created role of chief business officer.

Genome 40

Genome Genomics Medicine Life Science 40

Drug Discovery World

AUGUST 10, 2022

If the gene does not integrate into the genome, the cell will not become a CAR T cell. Furthermore, even if the transgene enters the cell in the correct numbers, the location where the gene integrates into the genome is somewhat random. The gene could also bury itself in a silenced region of the genome, leaving the gene dormant.

Manufacturing 98

Manufacturing Gene Genome Genomics 98

XTalks

FEBRUARY 27, 2024

XTALKS WEBINAR: A Collaborative Approach to Advancing Access and Equity in Rare Disease Clinical Trials Live and On-Demand: Thursday, February 29, 2024 , at 11am EST (4pm GMT / UK) Register for this free webinar to join the discussion with clinical trial experts on a collaborative approach to patient-friendly trials in rare disease.

Research 59

Research Drugs Gene Therapy Clinical Trials 59

XTalks

MAY 12, 2022

XTALKS WEBINAR: Using the Pain Catastrophizing Scale in Clinical Research and Practice. The detergent will denature the proteins and result in the release of the viral genomic DNA. Live and On-Demand: Thursday, June 09, 2022, at 11am EDT (4pm BST/UK).

In-Vitro 52

In-Vitro DNA Development Genome 52

Drug Discovery World

DECEMBER 8, 2023

The need for cell and gene therapy development standardisation Presently, a total of 3,866 cell and gene therapies are in various stages of development , spanning from pre-clinical research to pre-registration phases.

Gene Therapy 64

Gene Therapy Gene In-Vitro Development 64

XTalks

NOVEMBER 7, 2022

These tumor-derived entities are used to derive genomic and proteomic data. Detection of Genomic Alterations from cfDNA: Targeted, Non-Personalized Approaches. Detection of Genomic Alterations from cfDNA: Personalized, Targeted Assays. Non-personalized approaches can be both in-house or through a service provider.

Clinical Trials 98

Clinical Trials Clinical Trials Trials FDA Approval 98

XTalks

AUGUST 18, 2020

The study was funded by a clinical research agreement with the NBA and the players’ union – the National Basketball Players Association (NDG) – which together, contributed over $500,000 to fund the Yale study. The results of the two tests displayed almost universal equivalency.

FDA Approval 90

FDA Approval Reagent RNA Genome 90

XTalks

APRIL 24, 2023

“Rare disease clinical trials are complex due to the additional scientific, medical, operational and regulatory requirements of newly emerging advanced therapies, such as gene therapy,” says Dr. Terence Eagleton, MB BS, Senior Medical Director at the global clinical research organization (CRO) Medpace.

Gene Therapy 95

Gene Therapy Gene Trials Clinical Trials 95

Drug Discovery World

FEBRUARY 6, 2023

Johannes Goll, Global Head of Emmes’ Biomedical Data Science and Bioinformatics department, explains how big data analytics can deliver improved therapies and bring clinical research one step close to realising the potential of personalised care. He holds an MS degree in Statistics and a BS-equivalent in Bioengineering.

Big Data 52

Big Data RNA Bioinformatics Vaccination 52

XTalks

NOVEMBER 19, 2021

Dr. Januzzi describes a “biomarker Phase II,” which involves applying an unbiased inductive approach using omics-based approaches, such as proteomics, metabolomics, genomics and transcriptomics, to identify plausible drug-marker pairs. This also means beginning to look at cardiac biomarkers critically earlier during the trial process.

Clinical Trials 98

Clinical Trials Clinical Trials Trials In-Vitro 98